Postdoctoral fellow, School of Medicine, University of California, Irvine, USA, United States🌟
Dr. Mahmoud Singer is a dedicated researcher and postdoctoral scientist specializing in tumor immunology and cancer immunotherapy. 🌿 With expertise in immunology, molecular biology, and radiological sciences, he has contributed significantly to advancing liver and colorectal cancer treatments. His career spans academia and industry, including roles in medical equipment applications and pharmaceutical marketing. 🌎 Based in Los Angeles, USA, Dr. Singer actively pursues innovative therapeutic approaches to improve patient outcomes.
Profile
Google Scholar
Education 🎓
Dr. Singer earned his Doctorate in Biochemistry (Immunology & Cancer Biology) from Ain Shams University, Egypt. 📜 His research introduced novel immunotherapeutic models for liver cancer, integrating cutting-edge techniques in molecular biology and biochemistry. 🌟 With a robust academic foundation, he continues to enhance the field of cancer research.
Experience 🩺
Currently a Postdoctoral Scientist at the University of California, Irvine, Dr. Singer leads groundbreaking research on immunotherapy for hepatocellular carcinoma (HCC) and colorectal cancer. 🧬 His past roles include Onco-Immunologist at City of Hope National Medical Center and Lecturer at Cairo University. Dr. Singer’s work bridges laboratory science and clinical applications. 🥼
Research Interests 🔬
Dr. Singer focuses on immuno-oncology, viral immunology, and vaccines. 💉 His projects include innovative approaches to immune suppression, T-cell therapy, and targeted cancer treatments. His research reflects a passion for translating immunological discoveries into actionable therapies. 🌐
Awards 🏆
Dr. Singer’s efforts in cancer immunotherapy have been recognized with multiple accolades, including contributions to NIH grant applications and patent-pending innovations in BCMA-targeted therapy. 🌟 His dedication to science continues to drive advancements in oncology.
Publications Top Notes 📚
Structural glycoprotein E2 of classical swine fever virus interacts with host protein dynactin subunit 6 (DCTN6) during the virus infectious cycle
Journal of Virology, 94(1), 2019 (Cited by: 14)
Role of TNF-alpha as a survival prognostic marker in chronic lymphocytic leukemia patients
Egypt J Immunol, 18(1), 2011 (Cited by: 13)
Cross-protection induced by highly conserved human B, CD4+, and CD8+ T-cell epitopes-based vaccine against severe infection, disease, and death caused by …
Frontiers in Immunology, 15, 2024 (Cited by: 11)
Cytokine profiling as a prognostic marker in chronic myeloid leukemia patients
Egypt J Immunol, 18, 2011 (Cited by: 9)
A multi-epitope/CXCL11 prime/pull coronavirus mucosal vaccine boosts the frequency and the function of lung-resident memory CD4+ and CD8+ T cells and …
Journal of Virology, 97(12), 2023 (Cited by: 7)
Mucosal CCL28 Chemokine Improves Protection against Genital Herpes through Mobilization of Antiviral Effector Memory CCR10+ CD44+ CD62L− CD8+ T Cells and Memory CCR10+ B220+ …
The Journal of Immunology, 211(1), 2023 (Cited by: 6)
Mechanism of Action of Oral Salmonella-Based Vaccine to Prevent and Reverse Type 1 Diabetes in NOD Mice
Vaccines, 12(3), 2024 (Cited by: 4)
Conclusion
Dr. Mahmoud Singer is highly suitable for the Best Researcher Award, given his significant contributions to cancer immunotherapy, impactful publications, and innovative research in immuno-oncology. 🎖️ With continued focus on leadership and global collaborations, Dr. Singer has the potential to achieve even greater recognition in his field. His commitment to advancing therapeutic strategies and improving patient outcomes makes him a deserving candidate. 🌟